PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 3–3 | Cite as

13-Valent pneumococcal conjugate vaccine better value for money

Clinical study


  1. Wilson M, et al. Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada. Infectious Diseases and Therapy : 22 Jun 2018. Available from: URL: Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations